Vinorelbine and/or Gemcitabine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Sponsor
Istituto Nazionale per lo Studio e la Cura dei Tumori
Study ID
NCT00003447
Phase
PHASE3
Status
Unknown

Conditions

Eligibility Criteria

Sex
ALL
Age
70 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of vinorelbine, gemcitabine, or both in treating patients who have stage IIIB or stage IV non-small cell lung cancer.

Key Dates

First listed
May 21, 2004
Start date
Jul 31, 1998
Status verified
Sep 2007

Study Design

Enrollment
630 participants (estimated)
Allocation
RANDOMIZED
Primary purpose
TREATMENT

Related Studies